Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China flag China · Delayed Price · Currency is CNY
25.41
+0.24 (0.95%)
May 6, 2026, 3:00 PM CST

SHA:603983 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,18913,29312,93610,13313,54512,806
Market Cap Growth
-31.34%2.76%27.66%-25.19%5.77%-38.83%
Enterprise Value
9,06011,87911,1578,86712,28110,808
Last Close Price
25.4133.1531.6724.1932.0230.02
PE Ratio
47.7353.7737.8739.0677.7651.65
Forward PE
29.8727.3629.6930.8945.4534.27
PS Ratio
2.923.844.364.557.827.17
PB Ratio
2.923.923.752.964.164.06
P/TBV Ratio
3.354.534.833.865.555.52
P/FCF Ratio
81.46193.70-120.67--
P/OCF Ratio
30.0948.5443.0529.98279.64-
PEG Ratio
-3.373.373.373.373.81
EV/Sales Ratio
2.593.433.763.987.096.05
EV/EBITDA Ratio
34.8040.9430.6746.1479.6946.62
EV/EBIT Ratio
47.2351.3432.8950.5889.2649.96
EV/FCF Ratio
72.43173.09-105.59--
Debt / Equity Ratio
0.130.120.230.080.080.01
Debt / EBITDA Ratio
1.801.372.161.281.650.08
Debt / FCF Ratio
3.755.80-3.04--
Net Debt / Equity Ratio
-0.34-0.41-0.49-0.55-0.48-0.52
Net Debt / EBITDA Ratio
-4.59-4.81-4.61-9.72-10.21-7.07
Net Debt / FCF Ratio
-9.51-20.34105.88-22.2525.1913.16
Asset Turnover
0.740.720.620.520.440.47
Inventory Turnover
3.943.944.054.113.844.73
Quick Ratio
1.441.551.592.152.883.00
Current Ratio
1.971.871.852.503.353.43
Return on Equity (ROE)
6.01%7.21%9.97%8.32%5.22%7.83%
Return on Assets (ROA)
2.53%2.99%4.46%2.56%2.19%3.58%
Return on Invested Capital (ROIC)
7.50%10.25%18.39%9.51%6.98%15.78%
Return on Capital Employed (ROCE)
5.50%6.80%9.80%5.10%4.00%6.80%
Earnings Yield
2.09%1.86%2.64%2.56%1.29%1.94%
FCF Yield
1.23%0.52%-0.12%0.83%-0.46%-0.97%
Dividend Yield
1.99%1.51%2.37%2.15%0.78%0.63%
Payout Ratio
141.06%121.70%91.66%40.90%44.08%57.24%
Buyback Yield / Dilution
0.48%0.78%-0.70%1.47%-1.30%0.12%
Total Shareholder Return
2.47%2.29%1.66%3.62%-0.52%0.75%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.